{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:31:46Z","timestamp":1791232306994,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochirurgie"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.neuchi.2008.02.018","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T09:29:30Z","timestamp":1208338170000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["La pharmacor\u00e9sistance des \u00e9pilepsies partielles\u00a0: \u00e9pid\u00e9miologie, m\u00e9canismes, pharmacog\u00e9n\u00e9tique, perspectives th\u00e9rapeutiques"],"prefix":"10.1016","volume":"54","author":[{"given":"M.W.","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1528-1157.1979.tb04857.x","article-title":"Remission of seizures and relapse in patients with epilepsy","volume":"20","author":"Annegers","year":"1979","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1528-1157.2002.38501.x","article-title":"Is refractory epilepsy preventable?","volume":"43","author":"Arroyo","year":"2002","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0893-133X(98)00114-6","article-title":"Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia","volume":"21","author":"Basile","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuchi.2008.02.018_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1167.2007.00994.x","article-title":"Plasticity of antiepileptic drug targets","volume":"48","author":"Beck","year":"2007","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1528-1167.2006.00440.x","article-title":"Defining intractability: comparisons among published definitions","volume":"47","author":"Berg","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1212\/01.WNL.0000031792.89992.EC","article-title":"How long does it take for partial epilepsy to become intractable?","volume":"60","author":"Berg","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1528-1157.1996.tb00003.x","article-title":"Complex febrile seizures","volume":"37","author":"Berg","year":"1996","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.neuchi.2008.02.018_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1212\/WNL.56.11.1445","article-title":"Early development of intractable epilepsy in children: a prospective study","volume":"56","author":"Berg","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.20852","article-title":"How long does it take for epilepsy to become intractable? A prospective investigation","volume":"60","author":"Berg","year":"2006","journal-title":"Ann. Neurol."},{"issue":"16","key":"10.1016\/j.neuchi.2008.02.018_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: the multidrug resistance-associated proteins","volume":"92","author":"Borst","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.neuchi.2008.02.018_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.55.3.435","article-title":"APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy","volume":"55","author":"Briellmann","year":"2000","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.neuchi.2008.02.018_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1359-6446(01)01892-X","article-title":"Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy","volume":"6","author":"Brinkmann","year":"2001","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.neuchi.2008.02.018_bib13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/2661","article-title":"Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy","volume":"4","author":"Brooks-Kayal","year":"1998","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.21166","article-title":"Likelihood of seizure remission in an adult population with refractory epilepsy","volume":"62","author":"Callaghan","year":"2007","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/35052543","article-title":"Association study designs for complex diseases","volume":"2","author":"Cardon","year":"2001","journal-title":"Nat. Rev. Genet."},{"issue":"13","key":"10.1016\/j.neuchi.2008.02.018_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra022308","article-title":"Epilepsy","volume":"349","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"8968","key":"10.1016\/j.neuchi.2008.02.018_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1157.1997.tb01075.x","article-title":"Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study","volume":"38","author":"Cockerell","year":"1997","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.neuchi.2008.02.018_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res."},{"issue":"20","key":"10.1016\/j.neuchi.2008.02.018_bib20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199905203402008","article-title":"Patients with refractory seizures","volume":"340","author":"Devinsky","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.neuchi.2008.02.018_bib21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":"Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neuchi.2008.02.018_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/85045","article-title":"Drug delivery via the blood-brain barrier","volume":"4","author":"Edwards","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"15","key":"10.1016\/j.neuchi.2008.02.018_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJM198410113111503","article-title":"The prognosis for seizure control in newly diagnosed epilepsy","volume":"311","author":"Elwes","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1212\/01.WNL.0000046520.79877.D8","article-title":"GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy","volume":"60","author":"Gambardella","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1474-4422(04)00706-9","article-title":"Monogenic idiopathic epilepsies","volume":"3","author":"Gourfinkel-An","year":"2004","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.neuchi.2008.02.018_bib26","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1212\/WNL.40.8.1163","article-title":"Seizure recurrence after a 1st unprovoked seizure: an extended follow-up","volume":"40","author":"Hauser","year":"1990","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib27","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1531-8249(200012)48:6<948::AID-ANA21>3.0.CO;2-G","article-title":"Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis","volume":"48","author":"Heils","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ana.20872","article-title":"Cognitive prognosis in chronic temporal lobe epilepsy","volume":"60","author":"Hermann","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.neuchi.2008.02.018_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2007.06.003","article-title":"Predictors of pharmacoresistant epilepsy","volume":"75","author":"Hitiris","year":"2007","journal-title":"Epilepsy Res."},{"issue":"7","key":"10.1016\/j.neuchi.2008.02.018_bib30","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14622416.6.4.411","article-title":"Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response","volume":"6","author":"Hung","year":"2005","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/1531-8249(200005)47:5<571::AID-ANA3>3.0.CO;2-A","article-title":"Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy","volume":"47","author":"Kanemoto","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.seizure.2005.11.001","article-title":"Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics","volume":"15","author":"Kim","year":"2006","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.neuchi.2008.02.018_bib34","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1388-2457(99)00068-1","article-title":"EEG and clinical predictors of medically intractable childhood epilepsy","volume":"110","author":"Ko","year":"1999","journal-title":"Clin. Neurophysiol."},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.neuchi.2008.02.018_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1474-4422(06)70500-2","article-title":"Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study","volume":"5","author":"Leschziner","year":"2006","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs","volume":"301","author":"L\u00f6scher","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00023210-200721020-00005","article-title":"Various pharmacogenetic aspects of antiepileptic drug therapy: a review","volume":"21","author":"Mann","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuchi.2008.02.018_bib40","doi-asserted-by":"crossref","unstructured":"Mattson, R.H., Cramer, J.A. et al., 1996. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology 47 (1), 68\u201376.","DOI":"10.1212\/WNL.47.1.68"},{"issue":"10","key":"10.1016\/j.neuchi.2008.02.018_bib41","first-page":"819","article-title":"Recent insights about genetics of human idiopathic epilepsies and febrile seizures","volume":"156","author":"Moulard","year":"2000","journal-title":"Rev. Neurol. (Paris)"},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/WNL.63.6.955","article-title":"Association of genetic loci: Replication or not, that is the question","volume":"63","author":"Ott","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2125.2001.01359.x","article-title":"Carbamazepine is not a substrate for P-glycoprotein","volume":"51","author":"Owen","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.neuchi.2008.02.018_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.12.007","article-title":"Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats","volume":"58","author":"Potschka","year":"2004","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.10473","article-title":"A novel mechanism underlying drug resistance in chronic epilepsy","volume":"53","author":"Remy","year":"2003","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1528-1167.2005.40304.x","article-title":"GABA receptor 1 polymorphism (G1465A) and temporal lobe epilepsy","volume":"46","author":"Salzmann","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neuchi.2008.02.018_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0920-1211(99)00109-6","article-title":"Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy","volume":"39","author":"Sander","year":"2000","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nm0695-578","article-title":"The drug resistance-related protein LRP is the human major vault protein","volume":"1","author":"Scheffer","year":"1995","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.51.5.1256","article-title":"Is the underlying cause of epilepsy a major prognostic factor for recurrence?","volume":"51","author":"Semah","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuchi.2008.02.018_bib50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/14622416.7.4.551","article-title":"ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients","volume":"7","author":"Seo","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1528-1157.1988.tb03767.x","article-title":"EEG and other early predictors of epilepsy remission: a community study","volume":"29","author":"Shafer","year":"1988","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.neuchi.2008.02.018_bib52","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib53","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1528-1157.1993.tb02114.x","article-title":"Remission of seizures and predictors of intractability in long-term follow-up","volume":"34","author":"Sillanpaa","year":"1993","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib54","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1525-5050(02)00511-5","article-title":"P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice","volume":"3","author":"Sills","year":"2002","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.neuchi.2008.02.018_bib55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","article-title":"Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment","volume":"46","author":"Sills","year":"2005","journal-title":"Epilepsia"},{"issue":"Pt 1","key":"10.1016\/j.neuchi.2008.02.018_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/brain\/awf002","article-title":"Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy","volume":"125","author":"Sisodiya","year":"2002","journal-title":"Brain"},{"issue":"9249","key":"10.1016\/j.neuchi.2008.02.018_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(00)03573-X","article-title":"Multidrug-resistance protein 1 in focal cortical dysplasia","volume":"357","author":"Sisodiya","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1092852900008464","article-title":"The consequences of uncontrolled epilepsy","volume":"9","author":"Sperling","year":"2004","journal-title":"CNS Spectr."},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.mp.4000249","article-title":"Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients","volume":"2","author":"Steen","year":"1997","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.10108","article-title":"A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy","volume":"51","author":"Stogmann","year":"2002","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib61","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/01.WNL.0000137051.33486.C7","article-title":"Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy","volume":"63","author":"Tan","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuchi.2008.02.018_bib62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ana.10457","article-title":"Prodynorphin gene promoter polymorphism and temporal lobe epilepsy","volume":"53","author":"Tilgen","year":"2003","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib63","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archpedi.156.6.545","article-title":"Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions","volume":"156","author":"Tsai","year":"2002","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"10","key":"10.1016\/j.neuchi.2008.02.018_bib64","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/jnnp.74.10.1359","article-title":"Genetics of temporal lobe epilepsy","volume":"74","author":"Vadlamudi","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.neuchi.2008.02.018_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0920-1211(98)00061-8","article-title":"Effect of valproic acid on sodium currents in cortical neurons from patients with pharmaco-resistant temporal lobe epilepsy","volume":"32","author":"Vreugdenhil","year":"1998","journal-title":"Epilepsy Res."},{"issue":"11","key":"10.1016\/j.neuchi.2008.02.018_bib66","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1528-1157.1999.tb02034.x","article-title":"Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis","volume":"40","author":"Vreugdenhil","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuchi.2008.02.018_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/0470846356.ch6","article-title":"Drug resistance caused by multidrug resistance-associated proteins","volume":"243","author":"Wijnholds","year":"2002","journal-title":"Novartis Found. Symp."},{"issue":"6","key":"10.1016\/j.neuchi.2008.02.018_bib68","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/01.WNL.0000141021.42763.F6","article-title":"Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy","volume":"63","author":"Zimprich","year":"2004","journal-title":"Neurology"}],"container-title":["Neurochirurgie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377008000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028377008000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:24:08Z","timestamp":1758435848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028377008000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0028377008000386"],"URL":"https:\/\/doi.org\/10.1016\/j.neuchi.2008.02.018","relation":{},"ISSN":["0028-3770"],"issn-type":[{"value":"0028-3770","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La pharmacor\u00e9sistance des \u00e9pilepsies partielles\u00a0: \u00e9pid\u00e9miologie, m\u00e9canismes, pharmacog\u00e9n\u00e9tique, perspectives th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"Neurochirurgie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuchi.2008.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}